Clinical trial
A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers
NCT00262210 · National Health Research Institutes, Taiwan, Other · Completed
Key facts
| NCT number | NCT00262210 |
|---|---|
| Title | A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers |
| Official title | A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | Cyclophosphamide Epirubicin Etoposide Prednisolone |
| Enrollment | 50 |
| Start date | Jun 1, 1995 |
| Completion | Dec 1, 1999 |
| First posted | Dec 6, 2005 |
| Last update posted | Dec 6, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: